DDi

What DDi does

DDi is a privately held life sciences technology company that provides regulatory, clinical, and quality automation software to pharmaceutical, biotechnology, medical device, consumer health, and chemical companies. Founded in 1996 and headquartered in Monmouth Junction, New Jersey, with regional offices in London, Singapore, and Hyderabad, the company employs 51-100 people and serves enterprise clients including Pfizer, Roche, Merck, Bayer, Johnson & Johnson MedTech, B. Braun, Intuitive Surgical, Philips, Brainlab, and Cordis.

The company's product suite is built on a modular platform architecture and includes Visu (Regulatory Information Management and automation for submissions, UDI, and labeling), Vistaar (global regulatory intelligence and requirements monitoring), mIRT (Interactive Response Technology/RTSM for clinical trial randomization and supply management), TULA (clinical analytics and governance, risk, and compliance), smartDOC (enterprise document and content management), and REGai (an Agentic AI platform with dedicated agents for regulatory strategy, project management, and document workflows). Specialized modules include Visu UDI for multi-jurisdictional UDI compliance (FDA GUDID, EUDAMED, NMPA, TGA) and Visu eIFU for electronic labeling. AI capabilities span natural language processing for document extraction and proofreading, computer vision for label inspection, generative AI for submission drafting, anomaly detection for clinical monitoring, and predictive analytics for trial supply optimization. The proprietary smartRules engine encodes country-specific submission rules with automatic updates as regulations evolve.

DDi monetizes through annual software licensing for full-platform deployments, pay-per-use pricing for SMB customers with basic conversion needs, enterprise integration services, and ongoing professional services for implementation and PLM/ERP connectivity (SAP, Oracle, Agile PLM). The go-to-market is direct enterprise sales supported by a four-region footprint and content-led demand generation, with documented customer efficiency gains cited at 20-70%. The company is positioned in a regulatory information management market projected to grow from $2.41 billion in 2024 to $6.66 billion by 2034.

Name

DDi

Legal name

DDi Smart Technology

Website

https://ddismart.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

51–100 employees

Short description

DDi is a privately held life sciences technology company providing modular regulatory, clinical, and quality automation software, including its Visu RIM platform and REGai agentic AI suite, to BioPharma, medical device, and consumer health companies worldwide.

Ownership category

akta.pro rank

Product category

Life Sciences Regulatory Information Management Software

NAICS

Software Publishers (5132), Software Publishers (513210), Software Publishers (51321), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro industry

PRIMARYHLAGAJAM

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

• Regulatory information management
• Clinical trial supply
• Medical device compliance
• Pharmaceutical automation software
• UDI compliance management

Headquarters

HQ city

New Jersey

HQ country

Trinidad & Tobago

HQ region

Latin America

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Software Licensing (Annual License): Annual license model for platforms like Visu UDI with master data management functionality. Includes cloud-based validated solution with functional data management screens, data validation, and lifecycle maintenance.
2. Pay-per-use/Usage-based Model: Flexible pay-per-use model for companies with fewer products who need basic XML/XLS conversion. Simple portal access provided for upload, validation, and conversion to country-specific formats.
3. Professional Services: Consulting and implementation services for regulatory affairs, quality compliance, and system integration with existing enterprise systems like SAP, Oracle, and Agile PLM.
4. Enterprise Integration Services: Interfaces and connectors for PLM/ERP systems with data pull/push capabilities and ongoing technical support.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

DDi sells modular software platforms and automation solutions for life sciences companies to manage regulatory information, submissions, UDI, labeling, clinical trial supply, document management, and quality/compliance workflows. Its flagship suite — Visu, Vistaar, mIRT, TULA, smartDOC, and REGai — is sold as licensed software with subscription and pay-per-use models to BioPharma, medical device, consumer health, and chemical firms.

Product overview

DDi offers a modular platform architecture for Regulatory, Clinical, and Quality automation solutions for the life sciences industry. The product portfolio includes: Visu (Regulatory Information Management platform for RIM, Submission/Publishing, UDI and Labelling), Vistaar (Global Regulatory Intelligence, Requirements DB & Monitoring), mIRT (Clinical Trial Supply Management with randomization RTSM), TULA (Clinical Analytics & Risk Management with Governance, Risk and Compliance), smartDOC (Enterprise Document & Content Management), and REGai (Automation & Agentic AI Platform). The suite also includes specialized modules: Visu UDI for global Unique Device Identification compliance across FDA, EUDAMED, NMPA and other authorities, and Visu eIFU for electronic Instructions for Use management. Organizations can start with specific functional modules (e.g., RIM, UDI, IRT) and scale to full platform deployment as needed, benefiting from the integration across products for unified regulatory operations.

Differentiator

Problem solved

Functional benefit

Products and services

• Visu Regulatory Information Management (RIM) and process automation platform for life sciences, providing modular regulatory workflows including submission/publishing, UDI management, and labeling for BioPharma and medical device companies.
• Vistaar Global regulatory compliance and intelligence platform providing a regulatory requirements database and monitoring capabilities to help life sciences companies track and stay ahead of regulatory changes across markets.
• mIRT Clinical Trial Supply Management solution providing randomization (RTSM) and Interactive Response Technology (IRT) capabilities for patient allocation and drug supply across clinical trials.
• TULA Governance, Risk and Compliance (GRC) solution providing clinical analytics, risk management, and AI-powered automation for life sciences operations.
• smartDOC Enterprise Document and Content Management (EDMS) system providing intelligent content management for the regulatory documentation lifecycle in life sciences.
• REGai Automation and Agentic AI Platform providing AI agents for regulatory strategy, project management, and document management workflows, enabling AI-driven regulatory operations for life sciences teams.
• Visu UDI Unique Device Identification module within the Visu platform providing global UDI compliance management, automated regulatory data validation via the smartRules engine, and multi-market submission capabilities to FDA GUDID, EUDAMED, NMPA, TGA, and other health authorities, with machine-to-machine gateway connectivity.
• Visu eIFU Electronic Instructions for Use (eIFU) software for medical devices that enables digital labeling management, version control, and compliance with EU MDR, FDA, and global e-labeling requirements.

Quantifiable outcome

• Efficiency gains of 20% to 70%
• +2 more outcomes

Named customers23 records

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability11 records

Feature8 records

Partnerships

Four partnerships are on record, tiered core.

• SAPcoreTechnology or IntegrationVisu UDI integrates with SAP systems for seamless data pull/push from enterprise resource planning systems. Enables automated data synchronization for UDI and regulatory submissions.
• OraclecoreTechnology or IntegrationVisu UDI offers interfaces for Oracle integration, allowing bidirectional data flow between regulatory systems and Oracle-based enterprise platforms.
• Agile PLMcoreTechnology or IntegrationVisu UDI integrates with Agile PLM systems for product lifecycle management data integration, supporting UDI data maintenance and lifecycle updates.
• GS1coreTechnology or IntegrationDDi solutions support GS1 standards for UDI labeling and barcode identification, including GTIN and Global Location Number (GLN) encoding for FDA GUDID, EUDAMED, and other global health authority submissions.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Veeva Systems: Veeva's Vault RIM, Vault CTMS, Vault eTMF, and Vault Submissions are the most direct competitors to DDi's Visu, mIRT, and smartDOC products. Both target the same regulated pharma/medtech customer base with cloud-based regulatory and clinical software suites.
• ArisGlobal: ArisGlobal's LifeSphere RIMS, LifeSphere CTMS, and LifeSphere Signal compete head-to-head with DDi's regulatory, clinical, and safety offerings. Both are focused, domain-specific platforms serving similar pharma/biotech customers.
• MasterControl: MasterControl provides quality management, document control, and regulatory information management for life sciences - closely paralleling DDi's smartDOC and Visu offerings for medical device and pharma customers.
• Phlexglobal: Phlexglobal specializes in TMF and regulatory document management for clinical and submission workflows, directly overlapping with DDi's smartDOC and Visu submission/publishing capabilities.
• Generis (CARAT): Generis provides cloud-based RIM, submission management, and structured content authoring for life sciences, directly competing with DDi's Visu platform for the same mid-market and enterprise pharma/medtech customers.

Broad incumbents

• Oracle Health Sciences: Oracle's Clinical One, Argus Safety, and Siebel CTMS compete across DDi's clinical and regulatory portfolio as part of Oracle's broader life sciences application suite, often displacing smaller RIM vendors in large enterprise accounts.
• Sparta Systems (Honeywell): Sparta's TrackWise quality management system, now part of Honeywell, overlaps with DDi's TULA GRC and quality automation capabilities for regulated life sciences manufacturers.
• Dassault Systèmes BIOVIA: BIOVIA provides regulatory, quality, and scientific software for life sciences as part of Dassault's broader PLM platform, competing with DDi's RIM, UDI, and document management products particularly in medical device and chemical customers.
• IQVIA Technologies: IQVIA's regulatory technology and clinical trial solutions (including former Q² Solutions assets) overlap with DDi's RIM and IRT offerings, bundled with IQVIA's broader CRO and real-world data services.

Regional players

• Cegedim Life Sciences: Cegedim provides regulatory and clinical software (including its former Remscape and Globalcare platforms) primarily to European life sciences customers, overlapping with DDi's RIM/UDI offerings in EMEA geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/DDiSmart
• YouTubeyoutube.com/@DDiSmart
• Facebookfacebook.com/DDiSmart
• LinkedInlinkedin.com/company/ddismart
• Instagraminstagram.com/ddismart

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DDi